Literature DB >> 2290129

The study of clostridial and related toxins. The search for unique mechanisms and common denominators.

L L Simpson1.   

Abstract

Experiments have been conducted that deal with the structure and biological activity of clostridial toxins. Studies have dealt mainly with botulinum neurotoxin, but work has also been done with tetanus toxin and with the binary toxin. Structural studies indicate that proteolytic processing of botulinum neurotoxin induces two major outcomes: activation and aging. The first is associated with a marked increase in toxicity and with conversion from a single chain to a dichain structure. The second is associated with nominal changes in toxicity and with molecular rearrangements in the dichain structure. Immunological studies have resulted in isolation and characterization of a monoclonal antibody that neutralizes tetanus toxin. Monoclonal antibodies have also been raised against botulinum neurotoxin, and these antibodies have been used to demonstrate that: i) activation is not due to marked conformational changes in the relevant epitopes, ii) binding of the toxin to cholinergic nerve endings does not produce detectable conformational changes, and iii) all functional domains of the toxin appear to be internalized simultaneously. Immunological studies done in vivo and in vitro suggest that certain antibodies may enter cholinergic nerves and neutralize subsequently internalized toxin. Additional work on clostridial toxins has produced the following results: i) the ligand binding assay typically used with tetanus toxin (i.e., low pH and ionic strength) is of questionable biological significance, ii) the binary toxin, like the clostridial neurotoxins, enters cells by receptor-mediated endocytosis, and iii) tetanus toxin can alter the disposition of protein kinase C in one neuroblastoma cell line.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2290129

Source DB:  PubMed          Journal:  J Physiol (Paris)        ISSN: 0021-7948


  5 in total

1.  High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A.

Authors:  D D Pless; E R Torres; E K Reinke; S Bavari
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases.

Authors:  H Koprowski; Y M Zheng; E Heber-Katz; N Fraser; L Rorke; Z F Fu; C Hanlon; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

3.  Differential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissues.

Authors:  Z F Fu; E Weihe; Y M Zheng; M K Schäfer; H Sheng; S Corisdeo; F J Rauscher; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

4.  In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).

Authors:  Hamid Bakherad; Seyed Latif Mousavi Gargari; Iraj Rasooli; Masoumeh Rajabibazl; Mohammad Mohammadi; Walead Ebrahimizadeh; Leila Safaee Ardakani; Hamed Zare
Journal:  Mol Biotechnol       Date:  2013-10       Impact factor: 2.695

5.  Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A.

Authors:  M Zouhair Atassi; Behzod Z Dolimbek
Journal:  Protein J       Date:  2004-01       Impact factor: 4.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.